Clinuvel Pharmaceuticals Limited (ASX:CUV)
7.48
-0.11 (-1.45%)
Nov 17, 2026, 11:19 AM AEDT
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of 377.2 million as of November 16, 2026. It is the 18,875th most valuable company in the world and the 350th biggest in Australia. Its market cap has decreased by 32.19% in one year.
Market Cap
377.20M
Enterprise Value
127.08M
Revenue
94.02M
Global Rank
Country Rank
#350 Australia
PE Ratio
11.20
ChartMarket Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 377.20M, an increase of 7,118.23%. That is a compound annual growth rate of 18.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 377.20M | -39.70% |
| Dec 31, 2025 | 625.50M | 3.84% |
| Dec 31, 2024 | 602.36M | -24.90% |
| Dec 29, 2023 | 802.04M | -25.09% |
| Dec 30, 2022 | 1.07B | -20.36% |
| Dec 31, 2021 | 1.34B | 21.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 680.87M |
| Tetratherix | 347.53M |
| Racura Oncology | 331.36M |
| BLS Pharmaceuticals | 206.12M |
| Starpharma Holdings | 201.49M |
| Actinogen Medical | 173.15M |
| Orthocell | 155.26M |
| Paradigm Biopharmaceuticals | 153.48M |